Safety and Efficacy of Switching From Direct Oral Anticoagulants to Low Molecular Weight Heparin in Cancer Patients With Atrial Fibrillation During Antineoplastic Therapy
Latest Information Update: 07 Feb 2024
At a glance
- Drugs Bemiparin sodium (Primary) ; Dalteparin sodium (Primary) ; Enoxaparin sodium (Primary) ; Fondaparinux sodium (Primary) ; Nadroparin calcium (Primary) ; Tinzaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Stroke
- Focus Therapeutic Use
- Acronyms MAFIC
- 07 Feb 2024 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (Last Verified Feb 2022)
- 14 Feb 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 14 Feb 2022 Planned primary completion date changed from 1 Aug 2022 to 1 Aug 2023.